EG18112A - A process for preparing 3-propenyl cephalosporin solvates - Google Patents

A process for preparing 3-propenyl cephalosporin solvates

Info

Publication number
EG18112A
EG18112A EG469/86A EG46986A EG18112A EG 18112 A EG18112 A EG 18112A EG 469/86 A EG469/86 A EG 469/86A EG 46986 A EG46986 A EG 46986A EG 18112 A EG18112 A EG 18112A
Authority
EG
Egypt
Prior art keywords
preparing
solvates
propenyl cephalosporin
propenyl
cephalosporin solvates
Prior art date
Application number
EG469/86A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of EG18112A publication Critical patent/EG18112A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
EG469/86A 1985-07-29 1986-07-27 A process for preparing 3-propenyl cephalosporin solvates EG18112A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/759,805 US4694079A (en) 1985-07-29 1985-07-29 3-propenyl cephalosporin solvates

Publications (1)

Publication Number Publication Date
EG18112A true EG18112A (en) 1992-08-30

Family

ID=25057020

Family Applications (1)

Application Number Title Priority Date Filing Date
EG469/86A EG18112A (en) 1985-07-29 1986-07-27 A process for preparing 3-propenyl cephalosporin solvates

Country Status (17)

Country Link
US (1) US4694079A (fi)
KR (1) KR930004014B1 (fi)
CN (1) CN1015263B (fi)
AR (1) AR243530A1 (fi)
AT (1) AT389876B (fi)
CA (1) CA1262345A (fi)
CS (1) CS258143B2 (fi)
DD (1) DD248594A5 (fi)
EG (1) EG18112A (fi)
ES (1) ES2001338A6 (fi)
FI (1) FI84269C (fi)
GR (1) GR861988B (fi)
HU (1) HU195224B (fi)
NO (1) NO167461C (fi)
PT (1) PT83074B (fi)
SU (1) SU1414317A3 (fi)
YU (1) YU45350B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
AT399876B (de) * 1992-02-05 1995-08-25 Biochemie Gmbh Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー 3−セフェム−4−カルボン酸誘導体の精製方法
PT102061B (pt) * 1997-10-08 2000-06-30 J K Ind Ltd Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime
EP1447406B1 (en) * 1999-09-30 2006-08-09 Otsuka Kagaku Kabushiki Kaisha 3-Cephem derivative crystal
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(z)-프로페닐 세펨 화합물의 선택적인 제조 방법
US6903211B2 (en) * 2002-10-30 2005-06-07 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of 3-propenyl cephalosporin DMF solvate
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
EP1638520A2 (en) * 2003-06-19 2006-03-29 Ranbaxy Laboratories Limited Solvates of cefprozil
KR100576336B1 (ko) * 2003-10-30 2006-05-03 씨제이 주식회사 세팔로스포린 유도체의 제조방법
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
EP1809638B1 (en) 2004-11-01 2010-02-17 Hetero Drugs Limited A novel process for preparation of cefprozil intermediate
CN101058584B (zh) * 2007-05-23 2010-05-26 上海骏捷生化科技有限公司 一种制备头孢丙烯母核7-氨基-3-丙烯基头孢烷酸的方法
CN103524533B (zh) * 2013-10-10 2016-01-27 珠海金鸿药业股份有限公司 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法
CN108017658B (zh) * 2017-12-26 2020-06-16 山东裕欣药业有限公司 一种头孢丙烯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE3381408D1 (de) * 1982-12-27 1990-05-10 Lilly Co Eli Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins

Also Published As

Publication number Publication date
AR243530A1 (es) 1993-08-31
PT83074B (pt) 1989-06-30
CN1015263B (zh) 1992-01-01
DD248594A5 (de) 1987-08-12
FI84269B (fi) 1991-07-31
NO862970L (no) 1987-01-30
HUT41799A (en) 1987-05-28
ATA202886A (de) 1989-07-15
CA1262345A (en) 1989-10-17
GR861988B (en) 1986-12-22
HU195224B (en) 1988-04-28
CS258143B2 (en) 1988-07-15
SU1414317A3 (ru) 1988-07-30
NO167461C (no) 1991-11-06
ES2001338A6 (es) 1988-05-16
FI84269C (fi) 1991-11-11
KR870001216A (ko) 1987-03-12
CS561386A2 (en) 1987-09-17
US4694079A (en) 1987-09-15
YU45350B (en) 1992-05-28
FI863066A0 (fi) 1986-07-25
AT389876B (de) 1990-02-12
NO862970D0 (no) 1986-07-24
PT83074A (en) 1986-08-01
KR930004014B1 (ko) 1993-05-19
NO167461B (no) 1991-07-29
YU131086A (en) 1987-10-31
FI863066A (fi) 1987-01-30
CN86105568A (zh) 1987-04-01

Similar Documents

Publication Publication Date Title
GB2212910B (en) A workpiece-treatment apparatus
GB2226414B (en) Apparatus for monitoring a rotating member
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
EP0290696A3 (en) Apparatus for making a soft-ice drink
EP0307804A3 (en) New cephem compound and a process for preparation thereof
EG18112A (en) A process for preparing 3-propenyl cephalosporin solvates
EG18205A (en) Process for preparing cephalosporin intermediates
EG15934A (en) A method for preparing novel cephalosporin derivatives
GB8905175D0 (en) A culturing apparatus
EP0262744A3 (en) A process for preparing 3-alkoxymethylcephalosphorins
ZA86892B (en) Apparatus for replenshing a melt
EP0323724A3 (en) A method for stabilizing hydroisomerates
PH20486A (en) A process for producing a cephalosporin
GB2199851B (en) Apparatus for making a yarn
PT80715B (en) Process for preparing cephalosporin antibiotics
DE3660868D1 (en) Process for preparing ethyl-alpha-(1-carboxyethyl)-amino-gamma-oxo-gamma-phenylbutyrate
GR871012B (en) Process for preparing a mercaptoacylproline
PT83938A (en) Process for preparing nizatidine
PT80367A (en) Process for preparing cephalosporin compounds
GB2169779B (en) Apparatus for depicting a three-dimensional object
GB2156077B (en) Apparatus for providing a reference
PT80369A (en) Process for preparing cephalosporin compounds
YU146589A (en) Process for preparing new alylaminoethyl-azoles
EP0302181A3 (en) A process for preparing platinum-(ii)-cis-dichlorobis-(trishydroxymethylphosphine)
IL82770A0 (en) Process for preparing a cephem derivative